Oral delivery of proteins and peptides: Challenges, status quo and future perspectives

Quangang Zhu,Zhongjian Chen,Pijush Kumar Paul,Yi Lu,Wei Wu,Jianping Qi

DOI: https://doi.org/10.1016/j.apsb.2021.04.001

IF: 14.903

2021-08-01

Acta Pharmaceutica Sinica B

Abstract:<p>Proteins and peptides (PPs) have gradually become more attractive therapeutic molecules than small molecular drugs due to their high selectivity and efficacy, but fewer side effects. Owing to the poor stability and limited permeability through gastrointestinal (GI) tract and epithelia, the therapeutic PPs are usually administered by parenteral route. Given the big demand for oral administration in clinical use, a variety of researches focused on developing new technologies to overcome GI barriers of PPs, such as enteric coating, enzyme inhibitors, permeation enhancers, nanoparticles, as well as intestinal microdevices. Some new technologies have been developed under clinical trials and even on the market. This review summarizes the history, the physiological barriers and the overcoming approaches, current clinical and preclinical technologies, and future prospects of oral delivery of PPs.</p>

pharmacology & pharmacy

What problem does this paper attempt to address?

The paper attempts to address the challenges faced by the oral administration of proteins and peptides (PPs). Despite proteins and peptides becoming increasingly attractive therapeutic molecules compared to small molecule drugs due to their high selectivity and low toxicity, their poor stability and limited permeability in the gastrointestinal (GI) tract result in low oral bioavailability, often necessitating administration via injection. Therefore, the paper focuses on how to overcome these physiological barriers and improve the oral absorption of proteins and peptides to meet the clinical demand for oral administration.

Specifically, the paper discusses the following aspects:
1. **Historical Background**: Reviews the development history of oral administration of proteins and peptides, from the earliest attempts with insulin to some recent successful cases.
2. **Physiological Barriers**: Provides a detailed analysis of various physiological barriers in the gastrointestinal tract, including pH gradient, enzymatic degradation, mucus layer, epithelial barrier, and individual differences, all of which affect the stability and absorption of proteins and peptides.
3. **Formulation Factors**: Discusses key issues in formulation design, such as chemical and physical stability, aiming to ensure the stability of proteins and peptides during manufacturing, transportation, storage, and administration.
4. **Current Technologies and Future Prospects**: Summarizes the current technologies used to improve the oral absorption of proteins and peptides, including enteric coatings, enzyme inhibitors, permeability enhancers, nanoparticles, etc., and looks forward to future research directions and development prospects.

In summary, the paper aims to provide a comprehensive overview of the current status and challenges of oral administration of proteins and peptides and proposes possible solutions to promote further development in this field.